Desensitisation of mast cell β 2-adrenoceptor-mediated responses by salmeterol and formoterol

British Journal of Pharmacology

Volumn 141, Issue 1, 2004, Pages 163-171

  Scola, Anne Marie ^a   Chong, Lee K ^a   Suvarna, S Kim ^b   Chess Williams, Russell ^a   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

2 adrenoceptor; Formoterol; Mast cells; Salmeterol

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FORMOTEROL; FORSKOLIN; HISTAMINE; HISTAMINE RELEASE INHIBITOR; IMMUNOGLOBULIN E; ISOPRENALINE; PROSTAGLANDIN E2; SALMETEROL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INHIBITION KINETICS; MAST CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ALBUTEROL; CELL MEMBRANE; CYCLIC AMP; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FEMALE; FORSKOLIN; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; ISOPROTERENOL; LUNG; MALE; MAST CELLS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, BETA-2; TIME FACTORS;

EID: 1242341340     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705599     Document Type: Article

References (40)

1. ALI, H. & PEARCE, F.L. (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions, 16, 138-140.
2. ANDERSON, G.P., LINDEN, A. & RABE, K.F. (1994). Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J., 7, 569-578.
3. 2-agonists on inflammatory cells. J. Allergy Clin. Immunol., 104, S10-S17.
4. BERGENDAL, A., LINDEN, A., SKOOGH, B.-E., GERSPACHER, M., ANDERSON, G.P. & LÖFDAHL, C.-G. (1996). Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues. Br. J. Pharmacol., 117, 1009-1015.
5. BUTCHERS, P.R., SKIDMORE, I.F., VARDEY, C.J. & WHEELDON, A. (1980). Characterisation of the receptor mediating the anti-anaphylactic activities of β-adrenoceptor agonists in human lung tissue in vitro. Br. J. Pharmacol., 71, 663-667.
6. BUTCHERS, P.R., VARDEY, C.J. & JOHNSON, M. (1991). Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J. Pharmacol., 104, 672-676.
7. CHONG, L.K., CHESS-WILLIAMS, R. & PEACHELL, P.T. (2002). Pharmacological characterisation of the β-adrenoceptor expressed by human lung mast cells. Eur. J. Pharmacol., 437, 1-7.
8. 2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics, 10, 153-162.
9. CHONG, L.K., COOPER, E., VARDEY, C.J. & PEACHELL, P.T. (1998). Salmeterol inhibition of mediator release from human lung mast cells by β-adrenoceptor-dependent and independent mechanisms. Br. J. Pharmacol., 123, 1009-1015.
10. CHONG, L.K., MORICE, A.H., YEO, W.W., SCHLEIMER, R.P. & PEACHELL, P.T. (1995). Functional desensitization of β-agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol., 13, 540-546.
11. CHONG, L.K. & PEACHELL, P.T. (1999). β-Adrenoceptor reserve in human lung: a comparison between airway smooth muscle and mast cells. Eur. J. Pharmacol., 378, 115-122.
12. 2-adrenoceptor agonists in human lung mast cells. Br. J. Pharmacol., 138, 512-520.
13. CHURCH, M.K. & HIROI, J. (1987). Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmacol., 90, 421-429.
14. COCKCROFT, D.W., McPARLAND, C.P., BRITTO, S.A., SWYSTUN, V.A. & RUTHERFORD, B.C. (1993). Regular inhaled salbutamol and airway responsiveness to allergen. Lancet, 342, 833-837.
15. 2-adrenoceptor agonists. Trends Pharmacol. Sci., 17, 324-330.
16. DAHL, R. (1995). Comparative studies of inhaled salmeterol with other bronchodilators. Eur. Resp. Rev., 5, 138-141.
17. 2-adrenoceptor agonist salmeterol in guinea pig trachea. Br. J. Pharmacol., 104, 1057-1061.
18. DRURY, D.E.J., CHONG, L.K., GHAHRAMANI, P. & PEACHELL, P.T. (1998). Influence of receptor reserve on β-adrenoceptor-mediated responses in human lung mast cells. Br. J. Pharmacol., 124, 711-718.
19. sα. Br. J. Pharmacol., 132, 1261-1270.
20. 2-adrenoceptor agonists in asthma. Trends Pharmacol. Sci., 17, 331-336.
21. GILBERT, H.S. & ORNSTEIN, L. (1975). Basophil counting with a new staining method using Alcian Blue. Blood, 46, 279-282.
22. ISHIZAKA, T., CONRAD, D.H., SCHULMAN, E.S., STERK, A.R. & ISHIZAKA, K. (1983). Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J. Immunol., 130, 2357-2362.
23. 2-adrenoceptor. Br. J. Pharmacol., 123, 701-711.
24. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J. Biol. Chem., 272, 23871-23879.
25. 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br. J. Pharmacol., 113, 687-692.
26. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int. Arch. Allergy Immunol., 105, 177-180.
27. LEFKOWITZ, R.J. (1998). G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J. Biol. Chem., 273, 18677-18680.
28. LIPWORTH, B.J. & CLARK, D.J. (1997). Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax, 52, 1036-1039.
29. 2-agonists. Resp. Med., 95 (Suppl B), S7-S11.
30. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. NIALS, A.T., BALL, D.I., BUTCHERS, P.R., COLEMAN, R.A., HUMBLES, A.A., JOHNSON, M. & VARDEY, C.J. (1994). Formoterol on airway smooth muscle and human lung mast cells - a comparison with salbutamol and salmeterol. Eur. J. Pharmacol., 251, 127-135.
32. NIALS, A.T., COLEMAN, R.A., JOHNSON, M., MAGNUSSEN, H., RABE, K.F. & VARDEY, C.J. (1993). Effects of adrenoceptor agonists in human bronchial smooth muscle. Br. J. Pharmacol., 110, 1112-1116.
33. 2-agonists in asthma. N. Engl. J. Med., 327, 1204-1208.
34. SCHULMAN, E.S., MACGLASHAN, D.W., PETERS, S.P., SCHLEIMER, R.P., NEWBALL, H.H. & LICHTENSTEIN, L.M. (1982). Human lung mast cells: purification and characterisation. J. Immunol., 129, 2662-2667.
35. SIRAGANIAN, R.P. (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 283-287.
36. SVEDMYR, N. (1990). Action of corticosteroids on beta-adrenergic receptors. Am. Rev. Respir. Dis., 141, S31-S38.
37. VAN DER HEIJDEN, P.J.C.M., VAN AMSTERDAM, J.G.C. & ZAAGSMA, J. (1984). Desensitization of smooth muscle and mast cell β-adrenoceptors in the airways of the guinea pig. Eur. J. Resp. Dis., 65 (Suppl 135), 128-134.
38. 2-agonists. Thorax, 56, 529-535.
39. WALDECK, B. (2002). Adrenoceptor agonists and asthma - 100 years of development. Eur. J. Pharmacol., 445, 1-12.
40. YATES, D.H., WORDSELL, M. & BARNES, P.J. (1997). Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. Am. J. Respir. Care Med., 156, 988-991.